EUR 23.85
(-0.63%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 566.34 Million EUR | -0.47% |
2023 | 568.98 Million EUR | 4.23% |
2022 | 545.88 Million EUR | 12.77% |
2021 | 484.05 Million EUR | 13.53% |
2020 | 426.37 Million EUR | 29.51% |
2019 | 329.22 Million EUR | 4.62% |
2018 | 314.68 Million EUR | 61.22% |
2017 | 195.18 Million EUR | 50.99% |
2016 | 129.27 Million EUR | 22.73% |
2015 | 105.32 Million EUR | 21.1% |
2014 | 86.97 Million EUR | 26.93% |
2013 | 68.52 Million EUR | 12.46% |
2012 | 60.92 Million EUR | 10.53% |
2011 | 55.12 Million EUR | 24.55% |
2010 | 44.25 Million EUR | 4.18% |
2009 | 42.48 Million EUR | 11.87% |
2008 | 37.97 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q4 | 566.34 Million EUR | 0.0% |
2024 Q2 | 575.98 Million EUR | 0.0% |
2023 Q4 | 568.98 Million EUR | 0.0% |
2023 Q2 | 576.79 Million EUR | 0.0% |
2023 FY | 568.98 Million EUR | 4.23% |
2022 Q2 | 521.45 Million EUR | 0.0% |
2022 FY | 545.88 Million EUR | 12.77% |
2022 Q4 | 545.88 Million EUR | 0.0% |
2021 Q2 | 483.12 Million EUR | 0.0% |
2021 FY | 484.05 Million EUR | 13.53% |
2021 Q4 | 484.05 Million EUR | 0.0% |
2020 Q2 | 401.29 Million EUR | 0.0% |
2020 Q4 | 426.37 Million EUR | 0.0% |
2020 FY | 426.37 Million EUR | 29.51% |
2019 FY | 329.22 Million EUR | 4.62% |
2019 Q2 | 315.04 Million EUR | 0.0% |
2019 Q4 | 329.22 Million EUR | 0.0% |
2018 Q4 | 314.68 Million EUR | 0.0% |
2018 FY | 314.68 Million EUR | 61.22% |
2018 Q2 | 271.25 Million EUR | 0.0% |
2017 Q4 | 195.18 Million EUR | 0.0% |
2017 Q2 | 178.29 Million EUR | 0.0% |
2017 FY | 195.18 Million EUR | 50.99% |
2016 Q2 | 113.25 Million EUR | 0.0% |
2016 Q4 | 129.27 Million EUR | 0.0% |
2016 FY | 129.27 Million EUR | 22.73% |
2015 FY | 105.32 Million EUR | 21.1% |
2015 Q2 | 100.77 Million EUR | 0.0% |
2015 Q4 | 105.32 Million EUR | 0.0% |
2014 FY | 86.97 Million EUR | 26.93% |
2014 Q4 | 86.97 Million EUR | 0.0% |
2014 Q2 | 83.25 Million EUR | 0.0% |
2013 Q4 | 68.52 Million EUR | 0.0% |
2013 FY | 68.52 Million EUR | 12.46% |
2013 Q2 | 66.24 Million EUR | 0.0% |
2012 Q4 | 60.92 Million EUR | 0.0% |
2012 FY | 60.92 Million EUR | 10.53% |
2012 Q2 | 62.39 Million EUR | 0.0% |
2012 Q3 | 60.92 Million EUR | -2.35% |
2011 FY | 55.12 Million EUR | 24.55% |
2011 Q2 | 48.6 Million EUR | 0.0% |
2011 Q4 | 55.12 Million EUR | 0.0% |
2010 FY | 44.25 Million EUR | 4.18% |
2010 Q2 | 44.64 Million EUR | 0.0% |
2010 Q4 | 44.25 Million EUR | 0.0% |
2009 Q4 | 42.48 Million EUR | 0.0% |
2009 FY | 42.48 Million EUR | 11.87% |
2008 FY | 37.97 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Cegedim SA | 629.51 Million EUR | 10.035% |
Guerbet SA | 646.97 Million EUR | 12.462% |
Nexus AG | 153.13 Million EUR | -269.834% |
Revenio Group Oyj | 37.6 Million EUR | -1406.229% |
Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | 69.339% |
Sartorius Aktiengesellschaft | 6.99 Billion EUR | 91.907% |
LNA Santé SA | 1.19 Billion EUR | 52.75% |
Siemens Healthineers AG | 28.55 Billion EUR | 98.016% |
Medios AG | 125.94 Million EUR | -349.67% |
Equasens Société anonyme | 166.41 Million EUR | -240.311% |
Stratec SE | 246.2 Million EUR | -130.029% |